Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
Parabilis Medicines, Inc.
Ruijin Hospital
Eli Lilly and Company
Fudan University
I-Mab Biopharma US Limited
University Hospital, Akershus
Duke University
City of Hope Medical Center
UNICANCER
Memorial Sloan Kettering Cancer Center
Novartis
Federation Francophone de Cancerologie Digestive
University Health Network, Toronto
M.D. Anderson Cancer Center
Gruppo Oncologico del Nord-Ovest
Imugene Limited
Memorial Sloan Kettering Cancer Center
Immodulon Therapeutics Ltd
UNICANCER
Servier
Federation Francophone de Cancerologie Digestive
OHSU Knight Cancer Institute
The First Hospital of Jilin University
Asan Medical Center
University of Cologne
Jiangsu Cancer Institute & Hospital
Hoosier Cancer Research Network
National Cancer Institute, Naples
Ludwig-Maximilians - University of Munich
Brown University
EMD Serono
GSO Global Clinical Research BV
Fox Chase Cancer Center
UNICANCER
SCRI Development Innovations, LLC
Translational Oncology Research International
Grupo Espanol Multidisciplinario del Cancer Digestivo
AIO-Studien-gGmbH
UNICANCER
University of Florida
Odense University Hospital
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Herlev Hospital
AstraZeneca
Massachusetts General Hospital
ChineseAMS
The University of Hong Kong
NYU Langone Health